GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vita Life Sciences Ltd (ASX:VLS) » Definitions » Pretax Margin %
中文

Vita Life Sciences (ASX:VLS) Pretax Margin %

: 17.62% (As of Dec. 2023)
View and export this data going back to 2007. Start your Free Trial

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Vita Life Sciences's Pre-Tax Income for the six months ended in Dec. 2023 was A$6.96 Mil. Vita Life Sciences's Revenue for the six months ended in Dec. 2023 was A$39.47 Mil. Therefore, Vita Life Sciences's pretax margin for the quarter that ended in Dec. 2023 was 17.62%.

The historical rank and industry rank for Vita Life Sciences's Pretax Margin % or its related term are showing as below:

ASX:VLS' s Pretax Margin % Range Over the Past 10 Years
Min: 10.43   Med: 15.81   Max: 19.62
Current: 16.79


ASX:VLS's Pretax Margin % is ranked better than
78.24% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 4.58 vs ASX:VLS: 16.79

Vita Life Sciences Pretax Margin % Historical Data

The historical data trend for Vita Life Sciences's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vita Life Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.43 17.55 19.62 16.05 16.79

Vita Life Sciences Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.11 16.27 15.85 15.84 17.62

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vita Life Sciences's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vita Life Sciences Pretax Margin % Distribution

For the Drug Manufacturers industry and Healthcare sector, Vita Life Sciences's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Vita Life Sciences's Pretax Margin % falls into.



Vita Life Sciences Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Vita Life Sciences's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=12.451/74.161
=16.79 %

Vita Life Sciences's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=6.955/39.468
=17.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vita Life Sciences  (ASX:VLS) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Vita Life Sciences Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Vita Life Sciences's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Vita Life Sciences (ASX:VLS) Business Description

Traded in Other Exchanges
N/A
Address
Bath Road Kirrawee, Unit 1/ 102, Sydney, NSW, AUS, 2232
Vita Life Sciences Ltd is an Australian based pharmaceutical and healthcare company involved in formulating, packaging, sales, and distribution of vitamins and supplements. The company produces a wide range of premium supplements, vitamins, minerals, herbs and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, Herbs of Gold brands throughout Asia-Pacific region.

Vita Life Sciences (ASX:VLS) Headlines

No Headlines